about
Neurological complications in chronic kidney diseaseLoss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodentsChronic renal failure induces cell death in rat hippocampal CA1 via upregulation of αCaMKII/NR2A synaptic complex and phosphorylated GluR1-containing AMPA receptor cascades.Acute kidney injury leads to inflammation and functional changes in the brain.An overview of uremic toxicity.Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy.Guanidino compounds as uremic (neuro)toxins.Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders.Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins.The nature, consequences, and management of neurological disorders in chronic kidney disease.The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process.Systemic availability of guanidinoacetate affects GABAA receptor function and seizure threshold in GAMT deficient mice.Posterior reversible leukoencephalopathy syndrome as a presenting manifestation of p-ANCA-associated vasculitis.Plasma metabolomics profiling of maintenance hemodialysis based on capillary electrophoresis - time of flight mass spectrometry.Pitfall of bispectral index during intraoperative seizure -a case report-.Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease.Cerebral oxidative stress induces spatial working memory dysfunction in uremic mice: neuroprotective effect of tempol.Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans.Neurotoxicity associated with standard doses of piperacillin in an elderly patient with renal failure.Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes.Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis.Biodistribution of 99mTc-creatinine in rats with ablation nephropathy.Cerebrocellular swelling in the presence of uraemic guanidino compounds: ameliorative effects of taurine.Metabolomic analysis of the toxic effect of chronic exposure of cadmium on rat urine.Biodistribution of 99m technetium- labeled creatinine in healthy rats.Aberrant cortical thickness in neurologically asymptomatic patients with end-stage renal disease
P2860
Q28072242-96C2DD7B-DD85-4B9B-BAB6-60106AB6D8D2Q35003246-D9F1FAB5-5439-4A1F-8D90-4DED1E246BBCQ36466024-E1B25D99-EEE8-4FEA-A55E-E5759B31CADDQ36736770-47E0B28F-B52E-406C-89FB-00F2404C1967Q37451740-7D86AE80-7D9A-4F27-BDFA-4FC9D800483CQ37467960-D5F8D4CA-67B8-4820-B520-EA0EE0785AB1Q37587275-74FF7696-973A-4F95-83D5-1C69D4B8B438Q37847248-FFC48591-13A3-4C13-A0C1-1A7D08EEF16BQ37879580-102C2460-F23D-41F5-BF21-A3D671D83F3DQ38629122-C23D009F-2193-4F19-92CA-6564B0C2008EQ39946572-33312C49-FC0D-4FB3-99F3-341747E2EF76Q39981198-A0CB6B80-40CD-4284-8FAB-7C2D0AFA1DAFQ40110827-9DA86A1E-28F5-41E5-AA2F-51AAD6659A92Q41420103-62162B4D-361A-4C42-81AE-7C191990015EQ42123783-8B40EA8C-3539-4425-AD2D-33B4A8193A7EQ43862601-55EFF74F-A42B-43E9-AF56-98733DF82A4DQ44779627-46DCC65D-EBF9-47F7-95A7-32E6C084D94AQ44859078-9B965538-EB3C-4BA6-8AD6-E6373EAABFBDQ45981765-0E96567A-0FCA-41BF-967E-D36557BAB345Q46211956-730B292D-A603-4AD1-B44D-BFB323B2E7ADQ46231230-5C991E14-7AF5-46ED-9928-61AFD05264BEQ46783725-5E7FEF12-5966-484D-B2DB-0FF0CE462941Q46857404-9E81D466-ADBE-4B7D-91C1-D272DE1307E1Q47784881-971E236E-E20B-4D0C-AF81-A2A1938EF494Q48131056-957A2967-9212-4E50-871D-9E29AE331565Q58803507-49F4B04A-F463-4C06-9F0F-A4EC57E960CB
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Endogenous guanidino compounds as uremic neurotoxins.
@ast
Endogenous guanidino compounds as uremic neurotoxins.
@en
type
label
Endogenous guanidino compounds as uremic neurotoxins.
@ast
Endogenous guanidino compounds as uremic neurotoxins.
@en
prefLabel
Endogenous guanidino compounds as uremic neurotoxins.
@ast
Endogenous guanidino compounds as uremic neurotoxins.
@en
P2093
P1476
Endogenous guanidino compounds as uremic neurotoxins.
@en
P2093
De Deyn PP
Marescau B
Van Bogaert PP
P304
P356
10.1046/J.1523-1755.2001.59780077.X
P577
2001-02-01T00:00:00Z